Skip Navigation

A Phase I/II, Open-label Study of Oral MRT-2359 in Patients with MYC-Driven and Other Selected Solid Tumors Including Lung Cancer and Diffuse Large B-Cell Lymphoma

Brief Summary

Type:
Lung Cancers

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT05546268

Study #:
STUDY00150548

Start Date:
Aug 30, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05546268

View Complete Trial Details & Eligibility at ClinicalTrials.gov